The state of Iowa joined a number of other states in taking a stand against overly inflated drug prices. Pharmaceutical companies have been very successful convincing the public that the high cost of prescriptions is the result of trial lawyers and frivolous lawsuits. The fact is that pharmaceutical companies over inflate the price of their drugs by setting arbitrary price points that capitalize on the limited monopoly a patent gives a company.
It is a simple case of supply and demand. As consumers demand the product the insurance companies are forced to pay the huge increase because the product is not available from any other source. This type of abuse will not stop until there is a change in the way the U.S. patents pharmaceuticals. The U.S. is one of the only places in the word where a company can patent a drug without a cap on the price.
Think about it.